Scientific Publications Search Search Author Impact Factor Release Date Research Group Search Sort by RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Order AscDesc Beule, Dieter Dr. (3) Blankenstein, Thomas Prof. Dr. (1) Cakmak-Görür, Nese Dr. (1) Dörr, Jan Rafael (1) Haas, Simon Dr. rer. nat. (3) Holz, Maximilian (1) Höpken, Uta Elisabeth PD Dr. (1) Horne, Arik (1) Janz, Martin Dr. (5) Keller, Ulrich Dr. med. (85) Kempa, Stefan Dr. (1) Mathas, Stephan Dr. (4) Mertins, Philipp Dr. (2) Na, Il-Kang Dr. (3) Özerdem, Ceren (1) Pezzutto, Antonio Prof. Dr. (8) Popp, Oliver Dr. (1) Rhein, Simone Dr. (2) Schmitt, Clemens Prof. Dr. (2) Solé Boldo, Llorenc Dr. rer. nat. (1) Strzelecka, Paulina Maria (1) Walther, Wolfgang Prof. Dr. (2) Willimsky, Gerald Dr. (1) Yousefian, Schayan (2) 2013 (2) 2014 (2) 2015 (2) 2016 (1) 2019 (1) 2020 (11) 2021 (18) 2022 (21) 2023 (19) 2024 (10) Advanced Light Microscopy (43) AG Müller/Dechend (ECRC) (477) AG Schreiber [ECRC] (57) Allosteric Proteomics Lab (18) Anchored Signalling (114) Angiogenesis & Metabolism Laboratory (58) Animal Phenotyping (50) Biobank (429) Bioinformatics and Omics Data Science (90) Bioinformatics of RNA Structure and Transcriptome Regulation (47) Biology of Malignant Lymphomas (97) Biomedical Image Analysis (54) Cancer Genetics and Cellular Stress Responses (96) Cardiac MRI (286) Cardiovascular-Hematopoietic Interaction (16) Cell Biology of Immunity (66) Cellular Neurosciences (456) Chromatin (dys)function in disease (19) Clinical Research Unit (21) Clinic of Psychiatry / Modul Psychiatry of Aging (69) Computational methodologies and omic analytics (14) Computational Regulatory Genomics (168) Cryo-Electron Microscopy (18) Developmental Biology / Signal Transduction (211) Developmental Neurobiology (110) Development and Function of Neural Circuits (34) Electron Microscopy (7) Endocrinology, Diabetes and Nutritional Medicine (36) Epigenetic Modifications in Neuroblastoma (80) Epigenetic Regulation and Chromatin Architecture (130) Experimental Ultrahigh-Field MR (339) Flow Cytometry (8) From Cell States to Function (9) Gastrointestinal Barrier, Regeneration and Carcinogenesis (45) Genetics and Genomics of Cardiovascular Diseases (431) Genetics of Congenital Heart Disease (70) Genetics of Metabolic and Reproductive Disorders (24) Genome Diversification & Integrity (29) Genome Engineering & Disease Models (157) Genome instability and somatic mosaicism (41) Genomics (366) Host-microbiome factors in cardiovascular disease (139) Hypertension-caused End-Organ Damage (477) Hypertension-Mediated End-Organ Damage (477) Image Data Analysis (15) immune Cell Function in Health and Disease (47) Immune Dysregulations in Oncology (69) Immune Mechanisms and Human Antibodies (23) Immune Regulation and Cancer (98) Innate Immunity & Neuroinflammation (68) In Situ Structural Biology (56) Integrative Vascular Biology (162) Interdisciplinary Retina Research (111) Intracellular Proteolysis (138) Kidney Cell Engineering (17) Magnetic Resonance (339) Mathematical Cell Physiology (126) Mathematical Modelling of Cellular Processes (60) (-) Mechanism-based Cancer Therapies (87) Microenvironmental Regulation in Autoimmunity and Cancer (84) Mobile DNA (188) Molecular and cellular basis of behavio (9) Molecular Biology of Peptide Hormones (792) Molecular Cardiovascular Research (206) Molecular Epidemiology (429) Molecular Genetics of Chronic Inflammation and Allergic Disease (90) Molecular Immunology and Gene Therapy (239) Molecular mechanisms of environment sensing (12) Molecular Oncology (27) Molecular Pathways in Cortical Development (30) Molecular Physiology of Somatic Sensation (174) Myology (135) Nephrology and Inflammatory Vascular Diseases (159) Neural Circuits and Behaviour (63) Neuroimmunology Laboratory (52) Neurovascular link in neuroendocrine tumors (8) Non-coding RNAs and Mechanisms of Cytoplasmic Gene Regulation (28) Organoids (10) Out-patient Clinic for Neuroimmunology (691) Out-patient Clinic for Pediatric Allergology and Atopic Dermatitis (90) Pancreatic Organoid Research and Disease Modeling (130) Pathogenesis of ANCAinduced Glomerulonephritis (111) Pluripotent Stem Cells (74) Protein Production and Characterization (28) Proteome Dynamics (138) Proteomics (135) Proteomics and Metabolomics (100) Proteomics and Molecular Mechanisms of Neurodegenerative Diseases (378) Psychoneuroimmunology (47) Quantitative Developmental Biology (51) Quantitative Stem Cell Biology (28) RNA Biology and Posttranscriptional Regulation (142) Single Molecule Biophysics probing Quantitative Neuroscience (14) Spatial Proteomics (26) Stem Cell Dynamics and Mitochondrial Genomics (43) Stem Cell Modeling of Development and Disease (21) Structural Biology of Membrane-Associated Processes (111) Synaptic Transmission and Plasticity (210) Systems Biology Imaging (35) Systems biology of cardiovascular and neuronal pathologies (11) Systems Biology of Gene Regulatory Elements (190) Systems Hematology, Stem Cells & Precision Medicine (46) Transgenics (157) Translational Approaches in Heart Failure and Cardiometabolic Disease (121) Translational Bioinformatics (106) Translational Cardiology and Functional Genomics (103) Translational Neuroimmunology (56) Translational Oncology of Solid Tumors (919) Translational Organ Models (84) Translational Tumorimmunology (33) Tumor heterogeneity and treatment resistance in pediatric cancer (8) 87 Results: Active Filter: Mechanism-based Cancer Therapies Sort: Result score Newest to oldest Oldest to newest May 11, 2024 / Ann Hematol Plasmapheresis effectively abrogates severe liver toxicity of pegaspargase in a patient with acute lymphoblastic leukemia M. Tölle N. Gökbuget S. Habringer U. Keller S. Schwartz September 19, 2013 / Nature Synthetic lethal metabolic targeting of cellular senescence in cancer therapy J.R. Dörr Y. Yu M. Milanovic G. Beuster C. Zasada J.H.M. Däbritz J. Lisec D. Lenze A. Gerhardt K. Schleicher S. Kratzat B. Purfürst S. Walenta W. Mueller-Klieser M. Gräler M. Hummel U. Keller A.K. Buck B. Dörken L. Willmitzer M. Reimann S. Kempa S. Lee C.A. Schmitt January 20, 2013 / J Clin Oncol (90)Yttrium-ibritumomab-tiuxetan as first-line treatment for follicular lymphoma: 30 months of follow-up data from an international multicenter phase II clinical trial C.W. Scholz A. Pinto W. Linkesch O. Lindén A. Viardot U. Keller G. Hess S. Lastoria K. Lerch F. Frigeri M. Arcamone A. Stroux B. Frericks C. Pott A. Pezzutto October 01, 2021 / Leukemia CXCR4 hyperactivation cooperates with TCL1 in CLL development and aggressiveness R. Lewis H.C. Maurer N. Singh I. Gonzalez-Menendez M. Wirth M. Schick L. Zhang K. Isaakidis A.K. Scherger V. Schulze J. Lu T. Zenz K. Steiger R. Rad L. Quintanilla-Martinez M. Espeli K. Balabanian U. Keller S. Habringer June 01, 2015 / Ann Hematol Impact of prior treatment on outcome of transformed follicular lymphoma and relapsed de novo diffuse large B cell lymphoma: a retrospective multicentre analysis K. Lerch A.H. Meyer A. Stroux C. Hirt U. Keller A. Viardot R. Marks S. Schreiber A. Pezzutto C.W. Scholz April 01, 2016 / Leukemia Radioimmunotherapy in relapsed/refractory mantle cell lymphoma patients: final results of a European MCL network phase II trial S. Ferrero A. Pastore C.W. Scholz R. Forstpointner A. Pezzutto L. Bergmann L. Truemper J. Finke U. Keller P. Ghione R. Passera W. Hiddemann O. Weigert M. Unterhalt M. Dreyling October 12, 2021 / EJNMMI Res Rationale for MYC imaging and targeting in pancreatic cancer G. Schneider M. Wirth U. Keller D. Saur January 01, 2022 / Leuk Lymphoma Ibrutinib- and bortezomib-extended R-CHOP induction in elderly higher-risk patients newly diagnosed with diffuse large B-cell lymphoma - first analysis of toxicity and efficacy signals S. Denker A. Bittner M. Frick J. Kase J. Hoffmann C. Trenker U. Keller C. Bogner A. Hüttmann J. Dürig M. Janz S. Mathas R. Marks U. Krohn I.K. Na L. Bullinger C.A. Schmitt August 21, 2021 / EJNMMI Res Investigation of spleen CXCR4 expression by [(68)Ga]Pentixafor PET in a cohort of 145 solid cancer patients R. Lewis S. Habringer M. Kircher M. Hefter C.A. Peuker R. Werner V. Ademaj-Kospiri A. Gäble W. Weber H.J. Wester A. Buck P. Herhaus C. Lapa U. Keller July 30, 2021 / J Immunother Cancer High-affinity T-cell receptor specific for MyD88 L265P mutation for adoptive T-cell therapy of B-cell malignancies Ö. Çınar B. Brzezicha C. Grunert P.M. Kloetzel C. Beier C.A. Peuker U. Keller A. Pezzutto A. Busse Pagination Current page 1 Page 2 Page 3 Page 4 … Next page Next › Last page Last »
May 11, 2024 / Ann Hematol Plasmapheresis effectively abrogates severe liver toxicity of pegaspargase in a patient with acute lymphoblastic leukemia M. Tölle N. Gökbuget S. Habringer U. Keller S. Schwartz
September 19, 2013 / Nature Synthetic lethal metabolic targeting of cellular senescence in cancer therapy J.R. Dörr Y. Yu M. Milanovic G. Beuster C. Zasada J.H.M. Däbritz J. Lisec D. Lenze A. Gerhardt K. Schleicher S. Kratzat B. Purfürst S. Walenta W. Mueller-Klieser M. Gräler M. Hummel U. Keller A.K. Buck B. Dörken L. Willmitzer M. Reimann S. Kempa S. Lee C.A. Schmitt
January 20, 2013 / J Clin Oncol (90)Yttrium-ibritumomab-tiuxetan as first-line treatment for follicular lymphoma: 30 months of follow-up data from an international multicenter phase II clinical trial C.W. Scholz A. Pinto W. Linkesch O. Lindén A. Viardot U. Keller G. Hess S. Lastoria K. Lerch F. Frigeri M. Arcamone A. Stroux B. Frericks C. Pott A. Pezzutto
October 01, 2021 / Leukemia CXCR4 hyperactivation cooperates with TCL1 in CLL development and aggressiveness R. Lewis H.C. Maurer N. Singh I. Gonzalez-Menendez M. Wirth M. Schick L. Zhang K. Isaakidis A.K. Scherger V. Schulze J. Lu T. Zenz K. Steiger R. Rad L. Quintanilla-Martinez M. Espeli K. Balabanian U. Keller S. Habringer
June 01, 2015 / Ann Hematol Impact of prior treatment on outcome of transformed follicular lymphoma and relapsed de novo diffuse large B cell lymphoma: a retrospective multicentre analysis K. Lerch A.H. Meyer A. Stroux C. Hirt U. Keller A. Viardot R. Marks S. Schreiber A. Pezzutto C.W. Scholz
April 01, 2016 / Leukemia Radioimmunotherapy in relapsed/refractory mantle cell lymphoma patients: final results of a European MCL network phase II trial S. Ferrero A. Pastore C.W. Scholz R. Forstpointner A. Pezzutto L. Bergmann L. Truemper J. Finke U. Keller P. Ghione R. Passera W. Hiddemann O. Weigert M. Unterhalt M. Dreyling
October 12, 2021 / EJNMMI Res Rationale for MYC imaging and targeting in pancreatic cancer G. Schneider M. Wirth U. Keller D. Saur
January 01, 2022 / Leuk Lymphoma Ibrutinib- and bortezomib-extended R-CHOP induction in elderly higher-risk patients newly diagnosed with diffuse large B-cell lymphoma - first analysis of toxicity and efficacy signals S. Denker A. Bittner M. Frick J. Kase J. Hoffmann C. Trenker U. Keller C. Bogner A. Hüttmann J. Dürig M. Janz S. Mathas R. Marks U. Krohn I.K. Na L. Bullinger C.A. Schmitt
August 21, 2021 / EJNMMI Res Investigation of spleen CXCR4 expression by [(68)Ga]Pentixafor PET in a cohort of 145 solid cancer patients R. Lewis S. Habringer M. Kircher M. Hefter C.A. Peuker R. Werner V. Ademaj-Kospiri A. Gäble W. Weber H.J. Wester A. Buck P. Herhaus C. Lapa U. Keller
July 30, 2021 / J Immunother Cancer High-affinity T-cell receptor specific for MyD88 L265P mutation for adoptive T-cell therapy of B-cell malignancies Ö. Çınar B. Brzezicha C. Grunert P.M. Kloetzel C. Beier C.A. Peuker U. Keller A. Pezzutto A. Busse